Results 61 to 70 of about 65,372 (285)
Trials, 2020 Objectives A variety of possible mechanisms can make the nucleic acid test of patients who meet the discharge conditions positive again, including reinfection, reactivation of the original virus, lack of strict discharge criteria, new infection, and so ...
Jiawen Li +4 more
doaj +1 more source
Open source software, the future of medical imaging? [PDF]
, 2006 Medical imaging and Picture Archiving and Communication Systems (PACS) in particular, have appeared to be one of the promising areas for Open Source Software (OSS).
Bellika, Johan Gustav +3 more
core
British Journal of Clinical Pharmacology, EarlyView.Abstract Congenital ichthyoses (CI) are rare, inherited skin disorders characterized by hyperkeratosis, scaling and fissuring that significantly impair patients' quality of life. Treatment options are limited, with systemic retinoids reserved for severe cases owing to their adverse effect profile.
Holm Schneider +10 more
wiley +1 more source
Arbitration Agreements In Health Care: Myths and Reality [PDF]
, 1997 It is asserted that alternative dispute resolution methods, particularly mandatory binding arbitration agreements, have become the rule in health care delivery.
Moller, Erik +2 more
core +2 more sources
How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU
British Journal of Clinical Pharmacology, EarlyView.The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley +1 more source
Intravenous lanadelumab for the treatment of moderately ill COVID‐19 patients
British Journal of Clinical Pharmacology, EarlyView.Aims Kallikrein‐kinin system (KKS) dysregulation is hypothesized to play a pathogenetic role in COVID‐19‐associated pulmonary oedema. To investigate the efficacy and safety of intravenous lanadelumab, a monoclonal antibody that inhibits plasma kallikrein, in COVID‐19, we conducted a phase 2, open‐label, randomized‐controlled, proof‐of‐concept ...
Job J. Engel +12 more
wiley +1 more source
Julius – a template based supplementary electronic health record system
BMC Medical Informatics and Decision Making, 2007 Background EHR systems are widely used in hospitals and primary care centres but it is usually difficult to share information and to collect patient data for clinical research.
Klein Gunnar O, Enberg Gösta, Chen Rong
doaj +1 more source
A typology of schools across the four nations of the United Kingdom: Class, race and geography
British Educational Research Journal, EarlyView.Abstract In this paper we analyse the hierarchical field of schools across the United Kingdom during the transition to university and suggest that there are five socially distinct clusters of schools. Our five‐cluster typology of UK schools is composed of an established group of elite private and state schools, schools for the white rural and suburban ...
Sol Gamsu, Håkan Forsberg
wiley +1 more source
Counting Change: Measuring Health Care Prices, Costs, and Spending [PDF]
, 2012 Considers the accuracy and utility of current data on the determinants of healthcare costs, distorting factors that make measuring the costs of healthcare delivery difficult, the benefits of cost and spending measurement, and efforts to develop ...
core
How Supply Networks Influence Sustainable Innovation: Evidence From Ghana's Public Works Procurement
Business Strategy and the Environment, EarlyView.ABSTRACT Recent environmental and sustainability standards in procurement increase short‐term production and operational costs to suppliers, which are often recouped by charging price premiums for innovative solutions. However, public buyers are less likely to pay such price premiums, resulting in a disincentive among suppliers to bid for innovation ...
Peter Adjei‐Bamfo +5 more
wiley +1 more source